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ABSTRACT 
 
Background: Pulmonary embolism (PE) is a rare condition associated with high 
morbidity and mortality in children. The diagnosis of PE in children is challenging, 
considering the often non-specific clinical signs and symptoms associated with 
this condition. Computed tomography with pulmonary angiography (CTPA) is 
currently the diagnostic gold standard, but carries the risk of radiation-induced 
malignancy. For these reasons, the optimal diagnostic management strategy for 
the care of children with suspected PE in the emergency department (ED) setting 
is undefined.  
Objectives: We sought to describe associated clinical signs and symptoms and 
developed a clinical decision rule for the evaluation of children with suspected PE 
in the ED setting. In addition, we evaluated the Modified Wells Criteria and PERC 
(Pulmonary Embolism Rule-out Criteria) Rule by applying these established adult 
clinical decision rules against our population of children diagnosed with PE. 
Methods: We conducted a retrospective cohort study of children less than 21 
years of age undergoing diagnostic imaging for evaluation of PE from 2000 to 
2012. We included children who received either a CTPA or ventilation-perfusion 
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(V/Q) scanning for the evaluation of suspected PE. PE was defined by evidence 
of an occlusion in a pulmonary blood vessel or intermediate to high probability of 
PE reported in the diagnostic study results of the CTPA or V/Q scan, 
respectively. We additionally required the use of anticoagulant therapy to 
establish the diagnosis of PE. 
Results: Among 152 patients who presented to an ED setting, the prevalence of 
PE was 16.4%. The most frequent presenting symptoms in children with PE were 
chest pain (76%) and shortness of breath (44%), while the most common risk 
factors were presence of a CVC (16%), prolonged immobility (20%), and recent 
surgery (24%). The current use of oral contraceptive pill (P value = 0.010), 
abnormal lung exam (P value = 0.021), and oxygen saturation level (P value = 
0.003) were all significant findings that were more likely to be present in patients 
with PE. 
Conclusion: Our results describe a high risk population of children evaluated for 
PE presenting to an ED setting. We identified several historical, clinical, and 
physical exam findings that are independently associated with diagnosis of PE, 
such as current use of OCPs, abnormal lung exam, and oxygen saturation level. 
Next steps will be to use our descriptive analysis to develop a clinical decision 
rule for the evaluation and diagnosis of PE in children in an ED setting. 
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INTRODUCTION 
Venous thromboembolism (VTE) is a pathological condition where a clot, 
or thrombosis, forms in a blood vessel in the venous circulation (Patocka & 
Nemeth, 2012). These thrombi have a high tendency to form in the venous valve 
pockets, and can embolize and cause an occlusion. Because the systemic 
venous circulation of the lower extremities drain into the right atrium, clots 
originating in the legs may migrate and lodge in the pulmonary arteries (Tapson, 
2008; Patocka & Nemeth, 2012). Thus, VTE and more specifically deep vein 
thrombosis (DVT) can predispose an individual to develop a pulmonary embolism 
(PE). A PE is defined by the obstruction or partial occlusion of a pulmonary artery 
or subsequent branches due to an embolus or thrombosis (Babyn et al., 2005). 
PE can cause severe physiological changes in the patient, which can result in 
cardiac ischemia, vasospasm, and pulmonary hypertension (Patocka & Nemeth, 
2012). These physiological changes have high associated rates of morbidity and 
mortality, particularly in children. A massive PE, often due to a saddle embolus is 
a common cause of sudden death. 
The formation of thrombi is primarily influenced by three factors commonly 
known as Virchow’s triad: endothelial injury, alterations in normal blood flow, and 
blood hypercoagulability. Injury to the endothelium, the inner lining of blood 
vessels, results in the activation of the coagulation cascade to form a hemostatic 
plug. When the fibrinolytic system fails to regulate the growth of the hemostatic 
plug, the plug will continue growing, begin to affect blood flow, and potentially 
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develop into an occlusion, or thrombus. Changes to normal laminar blood flow, 
such as turbulence or stasis, can contribute to the formation of thrombi. Some of 
the mechanisms in which alterations in blood flow result in a thrombus include 
the following: 1) bringing platelets in contact with the endothelium, 2) hindering 
blood flow from diluting activated clotting factors, 3) preventing the transfer of 
fibrinolytic factors and allowing the growth of thrombi, and 4) activation of 
endothelial cells (Kuma et al., 2007). While both turbulence and stasis play a role 
in arterial and cardiac thrombosis, stasis typically has a larger contribution to the 
formation of venous thrombi. Alterations within the coagulation pathways are also 
known to predispose to development of a thrombosis. Hypercoagulable states 
can be further divided into either genetic or acquired disorders, such as Factor V 
Leiden mutation and heparin-induced thrombocytopenia (HIT) syndrome, 
respectively. The three factors of Virchow’s triad can promote the formation of a 
thrombus independently or in combination. After a thrombus forms, it can either: 
1) cause an obstruction where they form, 2) resolve by means of fibrinolytic 
activity, 3) become organized and allow for a re-establishment of flow or 4) 
embolize and move within the vasculature (Kuma et al., 2007). 
The potential for embolization make thrombi potentially serious conditions. 
This is of particular concern for DVTs originating in the lower extremities, as 
embolization of these clots may result in PE. Although the most common origin of 
PE is DVTs from the lower extremities, children can also have DVTs originating 
from upper extremity veins (Johnson et al., 2010). Obstruction involving the 
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pulmonary arterial circulation paired with continuing of ventilation of affected 
areas leads to ventilation-perfusion mismatch, hypoxemia, and an increase in 
alveolar dead space (Johnson et al., 2010). However, it should be noted that the 
size of the embolus as well as the general state of circulation largely determine 
the pathophysiological consequences of PE. 
PE is much more common in adults compared to children (Andrew et al., 
1994; Biss et al, 2008). However, studies show that the incidence of PE and VTE 
in the pediatric population is increasing (Andrew et al., 1994; Raffini et al., 2009). 
PE account for 86 per one million hospital admissions in children, yet this number 
maybe underestimated due to the fact that PE has a tendency to be clinically 
silent as well as masked by other underlying conditions (Biss et al., 2008). PE 
has been observed in up to 4.2% of children at autopsy, suggesting that the 
prevalence of PE in children is likely underestimated (Buck et al., 1981). The 
rising rates of PE and VTE in children is likely related to recent health care 
advances, such as increased use of central venous catheters and successful 
treatment and care of malignancies (Biss et al., 2008; Raffini et al., 2009).  
There are many reasons why PE tends to be difficult to diagnosis in 
children: rare occurrence, other medical conditions masking the clinical signs, 
and non-specific clinical symptoms (Dijk et al., 2012). Even though PE is known 
to be difficult to diagnosis, the literature has elucidated some risk factors 
commonly associated with PE (Biss et al., 2008). In adults, PE is most often 
associated with recent surgery, prolonged immobility, obesity, coronary heart 
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disease, oral contraceptive use, and pregnancy (Tapson, 2008). As detailed 
above, one of the most highly associated risk factors for PE is DVT. Studies 
show that about 95% of VTE in adults is associated with lower extremity DVT, 
while in children, studies show about 60 – 72% of PE cases also have DVT, with 
20% of those cases the patients having un upper extremity DVT (Dijk et al., 
2012). The major predisposing factors for PE in pediatric patients are presence 
of a central venous line or catheter (CVL or CVC), congenital heart disease, and 
signs of DVT (Dijk et al., 2012). Figure 1 summarizes three studies’ findings for 
risk factors of PE in children. As seen in Figure 1, the presence of a CVL is a 
significant and common risk factor for pediatric PE, as well as prior or current 
presence of DVT, and has been repeatedly supported throughout the literature. 
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Figure 1. Risk factors of pulmonary embolism in pediatric patients. This chart 
summarizes the relative findings on risk factors for pulmonary embolism (PE) in 
pediatric populations from three journal articles (Andrew et al. (1994), van 
Ommen et al. (2001), and Biss et al. (2008)) (Figure taken from Dijk et al., 2012). 
 
The clinical presentation of PE can vary greatly between patients 
emphasizing the difficulty in clinical diagnosis of this condition. These typically 
nonspecific clinical symptoms and signs include: pleuritic chest pain, shortness of 
breath, cough, and hemoptysis (Babyn et al., 2005, Johnson et al., 2010, Biss et 
al., 2008). Other signs that have also been present in patients with PE are 
tachycardia and fever (Johnson et al., 2010). Additionally, the literature shows 
clinical presentation of DVT is highly associated with the diagnosis of PE (Biss et 
al., 2008). 
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Differences in presentation and identification of PE between children and 
adults may be partially due to innate protective mechanisms in children (Dijk et 
al., 2012; Johnson et al., 2010). These proactive mechanisms in children have 
been described as decreased plasma concentrations of prothrombin resulting in 
a decreased ability to produce thrombin, increased plasma concentrations of 
alpha-2 macroglobulin resulting in a decreased ability to inhibit thrombin, and 
variations in interactions between blood vessel wall and platelets (Dijk et al., 
2012; Babyn et al., 2005). Another remarkable difference commonly seen 
between children and adults presenting with PE is in the age distribution. 
Children typically have a bimodal pattern of incidence, with peaks in infancy 
(often due to CVCs) and adolescence, while in adults incidence of PE typically 
increases with age (Place, 2005; Tapson, 2008). 
 Clinical decision rules for the evaluation of suspected PE have been 
developed and utilized in adults; however, due to the differences in predisposing 
factors associated with PE in children, these rules may not perform as well in 
children (Raffini et al., 2009; Biss et al, 2009). Two of the more common clinical 
decision rules used for the evaluation of PE in adults are the Wells simplified 
probability score and the Pulmonary Embolism Rule-out Criteria (PERC) rule. 
The Wells simplified probability score is a sum of seven, weighted variables that 
allows clinicians the ability to determine if patients presenting with symptoms are 
at high or low risk of harboring a PE. The seven criteria and the corresponding 
point values are listed in Table 1 (Wells et al., 2000; Wolf et al., 2004; Biss et al., 
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2009). While the Wells criteria was designed to evaluate patients at higher risk of 
PE, the PERC rule focuses mainly on identifying patients who have a very low 
risk of PE (Wells et al., 2001; Hugli et al., 2011; Biss et al., 2009). The PERC 
score is calculated from the sum of eight clinical criteria, which are all weighted 
equally, and listed in Table 2 (Hugli et al., 2011). Although the literature strongly 
supports the Wells simplified probability and PERC scores in adults, these 
clinical scores have not been previously validated in children. 
Table 1. The Modified Wells Criteria for clinical evaluation of pulmonary 
embolism. The seven factors are listed with their corresponding weighted point 
value (Wells et al., 2000; Wells et al., 2001). 
Modified Wells Criteria 
Risk Factors Point Value 
     Clinical symptoms of DVT 3.0 
     Diagnosis of PE most likely 3.0 
     Heart rate > 100 bpm 1.5 
     Immobilization (≥ 3 days) or surgery in the last 4 weeks 1.5 
     Previous DVT or PE 1.5 
     Hemoptysis 1.0 
     Malignancy 1.0 
Simplified clinical probability assessment 
Probability Score 
     PE Likely > 4.0 
     PE Unlikely ≤ 4.0 
 
 
 
 
 
 
 
 
 
 8
Table 2. The Pulmonary Embolism Rule-out Criteria (PERC) Rule. The eight 
factors are listed with each being worth one point. When all eight criteria are met, 
patients are considered to be at a very low risk of pulmonary embolism (Hugli et 
al., 2011). 
PERC Rule Factors 
     Age < 50 years 
     Heart rate < 100 bpm 
     Oxyhemoglobin saturation ≥ 95% 
     No hemoptysis 
     No oral contraceptive use (OCPs) 
     No prior DVT or PE 
     No unilateral leg swelling 
     No surgery or trauma within 4 weeks 
 
The diagnostic methods most commonly used for PE are fairly similar for 
both adults and children even though it is unknown how effective some of these 
methods are for determining PE in pediatric patients. The most common 
diagnostic techniques used are: pulmonary angiography, ventilation-perfusion 
(V/Q) scanning, magnetic resonance imaging (MRI), and computed tomography 
with pulmonary angiography (CTPA) (Patocka & Nemeth, 2012; Babyn et al., 
2005). CTPA is currently the diagnostic gold standard, but carries the potential 
risk of radiation-induced malignancy. The risk of radiation-induced malignancy is 
higher is children that adults due to children having an increased sensitivity of 
developing tissues and more time to manifest a radiation-induced malignancy 
(Frush et al., 2003). Additionally, some studies suggest that although these 
imaging modalities might be a sensitive screen for the diagnosis of PE in adults, 
they might not have the same test characteristics for the diagnosis of PE in 
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children (Lee et al., 2012; Dijk et al., 2012). Literature strongly supports using a 
combination of a clinical probability score, such as the Wells simplified probability 
score for PE, and D-dimer estimation, which is an assay analyzing the amount of 
a fibrin degradation by-product, in the evaluation of adult patients; however, there 
is evidence that even these methods of diagnosis lack utility in the evaluation of 
PE in children (Biss et al., 2009). Risk stratification based upon predisposing 
conditions, as well as clinical signs and symptoms may help to determine the 
best management strategy for children with suspected PE (Lee et al., 2012; Lee 
et al., 2012; Lee et al., 2011). 
 A sensitive and specific diagnostic method to establish a diagnosis of PE 
in children has not yet been described. With this study, we hope to better 
delineate the clinical signs and symptoms associated with PE in children, 
evaluate the Wells simplified probability score and PERC score, and to develop 
as clinical decision rule for the evaluation of children with suspected PE in the 
Emergency Department (ED) setting. 
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OBJECTIVES 
The prevalence of PE in children is low, and subsequently there is a 
paucity of literature around the optimal evaluation and management strategy for 
children presenting with symptoms suspicious for PE (Patocka & Nemeth, 2012; 
Babyn et al., 2005). The lack of literature is potentially due to several aspects 
that cause this condition to be difficult to diagnosis: rare occurrence, other 
medical conditions masking the clinical signs, and non-specific clinical 
symptoms. However, the existing literature suggests that prevalence of both DVT 
and PE are rising in children, which is concerning given that these conditions 
have high rates of associated morbidity and mortality (Andrews et al., 1994; 
Raffini et al., 2009). These factors, combined with the challenges in the clinical 
diagnosis of PE in children, make it a necessary topic of further research.  
In this study, we sought to define the risk factors associated with PE 
among children undergoing diagnostic imaging for suspicion of PE. By 
determining clinical risk factors in these patients, our future goal is to develop a 
guideline for the management of children presenting with symptoms associated 
with PE in the ED. We also evaluated existing scoring systems derived and used 
in adults (Wells simplified probability score and PERC score) for our cohort. 
Specific objectives of this study include: 1) To determine the risk factors of PE in 
a pediatric population from electronic medical records (EMR) and 2) To analyze 
the data gathered to further elucidate possible guidelines for diagnosis in the 
pediatric ED. 
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We hope that the development of this clinical decision rule will aid in the 
evaluation of PE in children presenting to the ED. In addition, we hope that a 
clinical decision rule will eventually help to target a more specific population, 
such as children with higher risk of PE. By more appropriately targeting patients 
with certain risk factors of PE, there is the potential to decrease unnecessary 
radiation exposure in pediatric patients assessed to be at low risk, which may 
additionally reduce overall health care costs. 
We conducted a large retrospective cohort study of children presenting to 
an ED and undergoing diagnostic imaging for suspicion of PE with the aims of: 1) 
describing the clinical signs and symptoms associated with PE, and 2) beginning 
to develop of a clinical decision rule for the evaluation of PE for children 
evaluated in the ED setting.  
 
 12 
METHODS 
Study Design 
 We conducted a retrospective cohort study of children less than 21 years 
of age undergoing diagnostic imaging for evaluation of PE from 2000 to 2012. 
We included children who received either a computed tomography with 
pulmonary angiography (CTPA) or ventilation-perfusion (V/Q) scanning for the 
evaluation of suspected PE. We included patient encounters only from the ED. 
Patients were excluded from the study if they had a current diagnosis of 
PE with or without current anticoagulant therapy. Patients who were currently 
taking anticoagulant therapy solely for a previous PE or current DVT or for 
indication other than PE (e.g. cardiac disease) were included.  
The study was conducted in a single, urban tertiary care Children’s 
Hospital. The study was approved by our hospital’s Institutional Review Board 
and patient confidentiality was protected in accordance with Health Insurance 
Portability and Accountability Act guidelines. 
 
Definitions 
 At our institution, Boston Children’s Hospital, the imaging technique of 
choice for clinically suspected PE in children is CTPA. However, for children who 
are known to have or are suspected of having an allergy to intravenous contrast 
media or significant renal disease, V/Q scanning is preferentially performed. In 
this study, patients were defined as having a PE if the diagnostic study results of 
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the CTPA or V/Q scan showed evidence of an occlusion in a pulmonary blood 
vessel or intermediate to high probability of PE, respectively. Additionally, 
classification of PE required treatment with an anticoagulant either in the ED or 
during the course of hospitalization. 
 
Data Collection 
 Data were abstracted from the EMR and entered into REDCap (Research 
Electronic Data Capture) hosted by Boston Children’s Hospital (Harris et al., 
2009). The data abstracted from the EMR were taken from the encounter 
associated with the diagnostic imaging, CTPA or V/Q scan. Specifically, the data 
collected included: basic demographic information (e.g. age and gender), 
presenting symptoms (e.g. presence and duration of chest pain, presence and 
duration of shortness of breath (SOB)), past medical history (e.g. previous DVT, 
malignancy, presence of CVL, obesity), current medications (e.g. aspirin, 
heparin), vital signs obtained in the ED (e.g. respiratory rate, blood pressure), 
physical exam findings (e.g. ausculatory findings, calf exam, reproducible chest 
pain), and laboratory findings (e.g. D-dimer values, complete blood count (CBC)). 
Also, additional diagnostic imaging results, such as chest x-rays (CXR), 
ultrasounds (US) of the extremities, electrocardiograms (EKG), and 
echocardiograms (ECHO) were abstracted. 
 More specifically, in regards to the past medical history, past surgeries 
were included in the data collection if they were within six months of the 
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encounter being reviewed; if multiple surgeries or procedures occurred within the 
six months prior to the imaging, the most recent surgery or procedure was 
recorded in our data collection. For the purpose of recording “immobility” in a 
patient’s past medical history, we decided “prolonged immobility” would be 
recorded for leg fractures and/or hospitalizations for seven days or more. 
 We utilized the ED, outpatient clinic, or inpatient hospital notes to obtain 
clinical information associated with the diagnostic imaging study. We included 
patients who underwent imaging during the course of hospitalization, associated 
with the ED visit. For hospitalized patients, all children had an ED visit within 
seven days of diagnostic imaging. The vital signs and laboratory studies most 
proximal to the diagnostic imaging studies were utilized. To more confidently 
confirm past surgical procedures, operative notes and anesthesia records were 
consulted. In addition, discharge summaries were used to acquire information 
regarding the entire hospital course. From the ED note, or other note used, 
details of the ED diagnosis and final diagnosis were extracted, and when 
appropriate, any anticoagulant treatment during the encounter was recorded. 
 
Evaluation of Wells Criteria and PE Rule-out Criteria (PERC) 
 We applied two well known clinical evaluation methods frequently used for 
diagnosis of PE in adult patients to our pediatric patients: the Modified Wells 
Criteria and the PE Rule-out Criteria (PERC) (Wells et al., 2000; Hugli et al., 
2011; Tapson, 2008)). The Modified Wells Criteria was evaluated using the 
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established criteria and simplified probability score listed in Table 1 (Wells et al., 
2000). For the category of “diagnosis of PE most likely,” if PE was listed in the 
differential diagnosis in the ED note, then we recorded the criterion as being 
fulfilled. The PERC score was calculated using the established criteria listed in 
Table 2 (Hugli et al., 2011). When calculating the PERC score, triage values from 
the ED visit were used for the criteria of “heart rate greater than 100 bpm” and 
“O2 saturation greater than or equal to 95%.”  
 
Statistical Analysis 
 All analysis was completed using SPSS 19.0 (SPSS Inc, Chicago, IL). All 
tests of significance were 2-sided, with a P value of less than 0.05 indicating a 
statistically significant difference. Univariate analysis was completed to evaluate 
the relationship between the various data collected, such as clinical findings and 
past medical history, and the presence of PE. The performance of the Modified 
Wells Criteria and PERC Rule were evaluated with respect to sensitivity, 
specificity, positive and negative predictive values, and positive and negative 
likelihood ratios. 
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RESULTS 
Patient Characteristics 
 We identified 281 children who underwent CTPA or V/Q scanning for 
evaluation of PE. Of those patients, 152 were evaluated in the ED within 7 days 
of imaging, and were included in the analysis. Table 3 shows the demographic 
and clinical characteristics of our study cohort. The median age was 15.9 years, 
with a majority of the sample being between the ages of 13.6 and 17.4 years. 
The subjects of this study were more likely to be female (63.8%). The most 
common historical findings among the subjects were: chest pain (66.4%), 
shortness of breath (44.1%), cough (20.4%), and fever (24.3%). Of patients with 
chest pain, 58 children (38.2%) described their chest pain as “pleuritic.” Seventy 
seven (51%) patients had at least one comorbidity, with presence of a CVC, 
prolonged immobility, and recent surgery occurring most commonly (14.5%, 
13.2%, and 25.7%, respectively). 15.1%  of patients were currently taking oral 
contraceptive pills (OCPs), while 11.2% were currently taking an anticoagulant, 
either Aspirin (n=7), Coumadin (n=3), or Heparin(n=8). 88.2% of patients had a 
CTPA performed and 17.1% of patients had a V/Q scan perform for the 
evaluation of PE, while 5.8% of patients underwent both a CTPA and a V/Q scan. 
Of the 152 patients, we found that 25 (16.4%) patients in our sample were 
diagnosed with PE in the ED. 
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Table 3. Demographics of study population (n=152). This table highlights notable 
characteristics among the study population – children presenting to the ED for 
the evaluation of PE. The characteristics listed include information, such as 
historical and physical exam findings recorded in the ED note.    
Characteristic N (%) 
Age in years (median [IQR]) 
   < 4.9 years 
   5-9.9 years 
   10-14.9 years 
   15-21.9 years 
15.9 [13.6.-17.4] 
1 (0.7) 
14 (9.2) 
39 (25.7) 
100 (64.5) 
Male (%) 55 (36.2) 
Historical Findings 
    Chest Pain 
    Cough 
    Shortness of Breath 
    Fever 
    Wheezing 
    Diaphoresis 
    Hemoptysis 
    Palpitations 
    Calf Pain 
    Calf Swelling 
    Upper Extremity Swelling 
    Upper Extremity Pain 
 
101 (66.4) 
31 (20.4) 
67 (44.1) 
37 (24.3) 
3 (2.0) 
3 (2.0) 
4 (2.6) 
11 (7.2) 
14 (9.2) 
9 (5.9) 
3 (2.0) 
12 (7.9) 
Any Comorbidity  
    CVC 
    Previous DVT 
    Previous PE 
    Thrombophilic Condition 
    Oncologic Condition 
    Cardiac Disease 
77 (51.0) 
22 (14.5) 
12 (7.9) 
2 (1.3) 
5 (3.3) 
14 (9.2) 
10 (6.6) 
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    Renal Disease 
    Autoimmune Disease 
    AV Malformation 
    Liver Disease 
    Sickle Cell 
    CCS Patient 
    Prolonged Immobility 
    Recent Surgery (within 6 months) 
3 (2.0) 
8 (5.3) 
2 (1.3) 
0 (0.0) 
1 (0.7) 
2 (1.3) 
20 (13.2) 
39 (25.7) 
Current Medication 
    OCP 
    Anticoagulant Use  
         Aspirin 
         Coumadin 
         Heparin 
 
23 (15.1) 
17 (11.2) 
7 (4.6) 
3 (2.0) 
8 (5.3) 
Family History 
    History of DVT 
    History of PE 
    Thrombophilic Condition 
 
5 (3.3) 
4 (2.6) 
7 (4.6) 
Social History 
    Smoker 
    Recent Air Travel 
 
6 (3.9) 
0 (0.0) 
D-dimer 
   % Obtained 
   Median (IQR) 
   % Positive (> 2.50 mg/L FEU) 
 
105 (69.1) 
3.25 (1.74 – 5.54) 
72 (68.6) 
Lung Exam 
    Obtained  
    Abnormal 
    Findings 
       Crackles or Rales 
 
151 (99.3) 
34 (22.4) 
 
10 (6.6) 
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       Coarse Breathing Sounds 
       Wheezes 
       Decreased Breathing Sounds 
       Tachypnea    
7 (4.6) 
3 (2.0) 
12 (7.9) 
17 (11.2) 
Reproducible Chest Pain 28 (18.4) 
Increased Work of Breathing 9 (5.9) 
Calf Exam 
    Obtained 
    Abnormal 
    Findings 
        Swelling 
        Erythema 
        Tenderness 
        Palpable Cord 
        Warmth 
 
44 (28.9) 
14 (31.8) 
 
8 (5.3) 
1 (0.7) 
6 (3.9) 
1 (0.7) 
0 (0.0) 
Imaging Modality 
     Pulmonary CTA 
     V/Q Scan 
     Both CTA and V/Q Scan 
 
134 (88.2) 
26 (17.1) 
9 (5.8) 
Diagnosis of PE 25 (16.4) 
Disposition 
    Home 
    Floor 
    Intensive Care 
 
48 (31.6) 
74 (48.7) 
30 (19.7) 
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Characteristics of Patients with PE 
 There were 25 patients diagnosed with PE in the ED. We observed that 
the median age was a little over 16 years old and 60% were female. The two 
most common complaints among children with PE were chest pain (n=19) and 
SOB (n=11). Six of the patients diagnosed with PE had surgery within six 
months, while 4 patients had an indwelling CVC. 32% of the patients with PE 
were on an OCP, while 3 patients (12%) were currently on some form of 
anticoagulant. Although none of the 25 patients with PE were recorded to have a 
murmur or increased work of breathing, 10 patients (40%) had lung exams with 
abnormal finding, such as crackles or rales, coarse or decreased breathing 
sounds, wheezes, or tachypnea.  
 
Univariate Analysis 
 Table 4 summarizes the findings of the univariate analysis we performed 
in our study. Demographic characteristics, such as age and sex did not differ 
between children with and without PE. Chest pain was reported as a chief 
complaint in 76% of patients with PE and almost 65% of patients without PE. 
There were no statistical significant differences in historical findings, such as 
chest pain or cough, found between patients with PE and without PE presenting 
in the ED. No single comorbidity reliably distinguished children with and without 
PE; however, patients with PE were more likely to have been taking OCPs 
compared to children without PE (32% vs. 12%, P value = 0.010). Triage 
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temperature, heart rate, and respiratory rate were not found to have a significant 
difference between patients diagnosed with PE from those without PE. However, 
triage O2 saturation values did significantly differ between patients who were 
diagnosed with and without PE with a P value of 0.003. In addition, a little over 
22% of this population of patients presented with abnormal lung exams and it 
was found that an abnormal lung exam was statistically significant between 
patients diagnosed with PE and those without PE (P value = 0.021). Four 
patients (16.0%) with PE were diagnosed at the time of the encounter with a 
lower extremity DVT, while 1 patient (4.0%) was diagnosed with a DVT of an 
upper extremity. A DVT positive ultrasound result was found to have a significant 
relationship with presence of a PE in patients that presented to the ED (P value = 
0.000).   
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Table 4. Univariate analysis of study population. This table highlights notable 
differences between children with and without PE as well the overall study 
population. The characteristics listed include information, such as historical and 
physical exam findings recorded in the ED note. The P values are listed and 
show the statistically significance between the PE and non-PE populations for 
each of the characteristics. 
Characteristics 
 
Cohort 
N (%) 
N = 154 
   
PE 
N (%) 
N = 25 
No PE 
N (%) 
N = 129 
P Value 
Physical Characteristic     
     Age (Mean [IQR]) 
15.9 
[13.6 - 17.4] 
16.9 
[13.0 - 17.7] 
15.8 
[13.7 - 17.3] 
0.390 
     Male 55 (36.2) 10 (40.0) 45 (35.4) 0.664 
Historical Findings     
     Chest Pain 101 (66.4) 19 (76.0) 82 (64.6) 0.268 
     Pleuritic Chest Pain 58 (38.2) 13 (52.0) 45 (35.4) 0.119 
     Cough 31 (20.4) 5 (20.0) 26 (20.5) 0.957 
     Shortness of Breath 67 (44.1) 11 (44.0) 56 (44.1) 0.993 
     Fever 37 (24.3) 7 (28.0) 30 (23.6) 0.641 
     Wheezing 3 (2.0) 1 (4.0) 2 (1.6) 0.426 
     Diaphoresis 3 (2.0) 0 (0.0) 3 (2.4) 0.438 
     Hemoptysis 4 (2.6) 0 (0.0) 4 (3.1) 0.369 
     Palpitations 11 (7.2) 0 (0.0) 11 (8.7) 0.127 
     Calf Pain 14 (9.2) 4 (16.0) 10 (7.9) 0.199 
     Calf Swelling 9 (5.9) 1 (4.0) 8 (6.3) 0.656 
     Upper Extremity Swelling 3 (2.0) 3 (12.0) 0 (0.0) 0.000 
     Upper Extremity Pain 12 (7.9) 2 (8.0) 10 (7.9) 0.983 
Comorbidity     
     CVC 22 (14.5) 4 (16.0) 18 (14.2) 0.812 
     Previous DVT 12 (7.9) 3 (12.0) 9 (7.1) 0.405 
     Previous PE 2 (1.3) 1 (4.0) 1 (0.8) 0.198 
     Thrombophilic Condition  5 (3.3) 1 (4.0) 4 (3.1) 0.828 
     Oncologic Condition 14 (9.2) 3 (12.0) 11 (8.7) 0.598 
     Renal Disease 3 (2.0) 1 (4.0) 2 (1.6) 0.426 
     Autoimmune Disease 8 (5.3) 1 (4.0) 7 (5.5) 0.757 
     AV Malformation 2 (1.3) 0 (0.0) 2 (1.6) 0.528 
     Liver Disease 0 (0.0) 0 (0.0) 0 (0.0) -- 
     Sickle Cell 1 (0.7) 0 (0.0) 1 (0.8) 0.656 
     CCS Patient 2 (1.3) 0 (0.0) 2 (1.6) 0.528 
     Prolonged Immobility* 20 (13.2) 5 (20.0) 15 (11.8) 0.268 
     Recent Surgery
#
 39 (25.7) 6 (24.0) 33 (26.0) 0.836 
Current Medications     
     OCP 23 (15.1) 8 (32.0) 15 (11.8) 0.010 
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     Anticoagulant Use     
          Aspirin 7 (4.6) 1 (4.0) 6 (4.7) 0.874 
          Coumadin 3 (2.0) 1 (4.0) 2 (1.6) 0.426 
          Heparin 8 (5.3) 1 (4.0) 7 (5.5) 0.757 
Family History     
     History of DVT 5 (3.3) 1 (4.0) 4 (3.1) 0.828 
     History of PE 4 (2.6) 0 (0.0) 4 (3.1) 0.369 
     Thrombophilic Condition 7 (4.6) 1 (4.0) 6 (4.7) 0.874 
Social History     
     Smoker 6 (3.9) 2 (8.0) 4 (3.1) 0.255 
     Recent Air Travel 0 (0.0) 0 (0.0) 0 (0.0) -- 
D-dimer Result (Median 
[IQR])† 
3.25 
[1.74 - 5.54] 
3.71 
[1.77 - 7.45] 
3.15 
[1.73 - 4.86] 
0.292 
Physical Exam (Median 
[IQR]) 
    
     Temperature
‡
 
36.9 
[36.4 - 37.4] 
36.9 
[36.4 - 37.1] 
36.9 
[36.4 - 37.5] 
0.484 
     Heart Rate
ε
 
98.0 
[80 – 113] 
104.0 
[88 - 117] 
94.5 
[80 - 113] 
0.162 
     Respiratory Rate
θ
 
20 
[18 - 25] 
22 
[20 – 27.5] 
20 
[18 - 25] 
0.084 
     Systolic Blood Pressure
π
 
120 
[112 - 130] 
118 
[111 - 127] 
120 
[112 - 132] 
0.305 
     Diastolic Blood Pressure
µ
 
69 
[62 - 78.3] 
67 
[59 - 78] 
69 
[62 - 79] 
0.347 
     O2 Saturation
φ
 
99 
[97 - 100] 
97 
[94 - 99] 
99 
[98 - 100] 
0.003 
     Weight
ω
 
61.5 
[53.1 - 83.0] 
71.6 
[48.7-102.4] 
61.1 
[54.9 - 79.2] 
0.407 
Lung Exam     
     Abnormal 34 (22.4) 10 (40.0) 24 (18.9) 0.021 
     Crackles or Rales 10 (6.6) 2 (8.0) 8 (6.3) 0.754 
     Coarse Breathing Sounds  7 (4.6) 1 (4.0) 6 (4.7) 0.874 
     Wheezes 3 (2.0) 1 (4.0) 2 (1.6) 0.426 
     Decreased Breathing     
Sounds 
12 (7.9) 3 (12.0) 9 (7.1) 0.405 
     Tachypnea 17 (11.2) 5 (20.0) 12 (9.4) 0.126 
Murmur 13 (8.6) 0 (0.0) 13 (10.2) 0.094 
Reproducible Chest Pain 28 (18.4) 2 (8.0) 26 (20.5) 0.141 
Increased Work of 
Breathing 
9 (5.9) 0 (0.0) 9 (7.1) 0.170 
Calf Exam     
     Abnormal 14 (31.8) 4 (44.4) 10 (28.6) 0.362 
     Swelling 8 (5.3) 2 (8.0) 6 (4.7) 0.503 
     Erythema 1 (0.7) 0 (0.0) 1 (0.8) 0.656 
     Tenderness 6 (3.9) 2 (8.0) 4 (3.1) 0.255 
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     Palpable Cord 1 (0.7) 0 (0.0) 1 (0.8) 0.656 
     Warmth 0 (0.0) 0 (0.0) 0 (0.0) -- 
Imaging Modality     
     Pulmonary CTA 134 (88.2) 23 (92.0) 111 (87.4) 0.515 
     V/Q Scan 26 (17.1) 5 (20.0) 21 (16.5) 0.674 
     Chest X-Ray 135 (88.8) 23 (92.0) 112 (88.2) 0.581 
     EKG 100 (65.8) 16 (64.0) 84 (65.8) 0.837 
     Lower Ext Doppler US 31 (20.4) 20 (80.0) 11 (8.7) 0.000 
     ECHO 40 (26.3) 18 (72.0) 22 (17.3) 0.000 
DVT Positive LE US  7 (4.6) 5 (20.0) 2 (1.6) 0.000 
*  = immobility refers to complete bed rest for 7 or more days in duration or lower extremity 
fracture; # = surgery within 6 months; † = Units mg/L; ‡ = Units °C; ε = Units bpm (beats per 
minute); θ = Units inspiration per minute; π = Units mmHg; µ = Units mmHg; φ = Units % 
saturation; ω = Units kg. 
 25 
D-dimer Results 
Out of 152 patients presenting to the ED, 105 (69.1%) had a D-dimer 
value obtained. The median D-dimer value was 3.25 mg/L Fibrinogen Equivalent 
Units (FEU), with an interquartile range (IQR) of 1.74 – 5.54 mg/L FEU (Table 4). 
D-dimer values were considered to be positive if the result was greater than 2.50 
mg/L FEU in our laboratory. Positive D-dimer values were observed in 72 
(47.4%) of the 152 patients. Out of the 25 patients who were diagnosed with PE 
by imagining studies, 13 patients had positive D-dimer results, while 5 had 
negative D-dimer results and 7 did not have a D-dimer value recorded in the 
EMR (Table 5). Among the 127 patients without out a diagnosis of PE, 59 had 
positive D-dimer results, while 28 had negative D-dimer results and 42 did not 
have a D-dimer recorded. This study found no statistically significant relationship 
between the presence of a positive D-dimer result and presence of PE.  
Table 5. D-dimer result comparison between patients with and without PE. 
Positive D-dimer (≥ 2.50 mg/L FEU) results were found in over 72% and 67% of 
patients with and without PE, respectively. There was no statistical significance 
between having a positive D-dimer value and a diagnosis of PE (P value = 
0.714). 
D-dimer Results 
PE (n = 18)  
[N (%)] 
No PE (n = 87)  
[N (%)] 
Negative ( < 2.50 mg/L FEU) 5 (27.8) 28 (32.2) 
Positive ( ≥ 2.50 mg/L FEU) 13 (72.2) 59 (67.8) 
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Analysis of the Modified Wells Criteria 
 We tested the Modified Wells score using our retrospectively collected 
data. The resulting Modified Wells scores for each of our 25 patients diagnosed 
with PE are listed in Table 6. Out of the 25 patients, 16 (64%) patients had a 
score greater than or equal to 4 points indicating the presence of PE is likely. 
There were 58 patients within the 127 patients without PE that were high risk 
(score ≥ 4) according the Modified Wells Criteria. All our patients met at least one 
of the criteria. Table 7 compares the children with and without PE and their 
relative Modified Wells scores. The sensitivity and specificity of this rule in our 
population were 64% (95% CI, 43 – 81%) and 54% (95% CI, 45 – 63%).  
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Table 6. The Modified Wells Criteria applied to patients diagnosed with PE. This 
table summarizes the Wells criteria present in the patients with PE as well as the 
respective score. The point values are listed with the respective criteria. A score 
≥ 4 indicated “PE likely” and < 4 indicated “PE unlikely” (Wells et al., 2000). 
 Wells Criteria 
Patient 
HR 
>100 
bpm 
(1.5) 
Abnormal 
Calf 
Exam 
(3.0) 
PE 
Most 
Likely 
(Y/N)
1
 
(3.0) 
Immobile 
or 
Surgery
2
 
(1.5) 
Prior 
PE 
or 
DVT 
(1.5) 
Hemoptysis 
(1.0) 
Malignancy 
(1.0) 
Score 
1 X  N X    3 
2   Y  X   4.5 
3   Y X    4.5 
4 X  Y     4.5 
5   Y X    4.5 
6 X X Y X    9 
7 X  N     1.5 
8 X  N     1.5 
9 X  Y     4.5 
10   Y     3 
11 X  Y     4.5 
12 X  Y  X   6 
13 X  N     1.5 
14 X  Y  X   6 
15 X  Y X X   7.5 
16   N X   X 2.5 
17 X  Y     4.5 
18 X X Y    X 8.5 
19 X X Y     7.5 
20  X
3 
N     3 
21 X  Y     4.5 
22   Y X    4.5 
23   Y     3 
24   Y     3 
25 X  Y    X 5.5 
1. If PE was listed in the differential diagnosis, the criterion was recorded as being fulfilled. If the 
criterion was unfulfilled, the other diagnosis was noted: patients 1, 13, 16, and 20 had other 
diagnoses of pneumonia, pneumonia, fever and neutropenia, and thigh pain, respectively. 
Patients 7 and 8 did not have a differential diagnosis recorded. 
2. Our study defined immobility as complete bed rest of ≥7 days in duration, lower extremity 
fracture, or surgery within 4 weeks. 
3. This patient had an abnormal lower extremity exam, more specifically left thigh pain. 
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Table 7. Modified Wells score comparison between patients with and without PE. 
Patients receiving a score of 4 or greater were recorded as positive or PE likely, 
while patients receiving a score of less than 4 were recorded as negative or PE 
unlikely.  
Score 
PE (n = 25)  
[N (%)] 
No PE (n = 127)  
[N (%)] 
Positive ( ≥ 4) 16 (64) 58 (46) 
Negative ( < 4) 9 (36) 69 (54) 
 
Analysis of PE Rule-out Criteria (PERC) 
 We tested the PERC score using our retrospectively collected data. The 
resulting PERC scores for each of our 25 patients diagnosed with PE are listed in 
Table 8. Out of the 25 patients with PE, all patients had a score 5 points or 
greater out of 8 points. One of the 25 patients with PE would have been ruled 
out, while 18 patients without PE would have been ruled out according to the 
PERC score calculated. The PERC score range for patients without PE was 3 to 
8 points. Table 9 shows the comparison of PERC positive and PERC negative 
score between children with and without PE. Thus, the sensitivity was 96% (95% 
CI, 78 – 100%) in our population. The specificity was calculated to be 9% (95% 
CI, 5 – 15%). Table 10 summarizes the performance of both the Modified Wells 
scores and PERC scores in our study’s ED population. 
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Table 8. The PERC Rule applied to patients diagnosed with PE (n=25). This 
table summarizes the various PERC criteria present in the patients diagnosed 
with PE as well as the respective PERC score. For the PERC score, only a score 
of 8 suggests the patient has a very low risk of PE (Hugli et al., 2011).  
 PERC Rule 
Patient 
Age 
< 50 
years 
HR 
< 
100 
bpm 
Sat 
> 
95% 
No 
Hemoptysis 
No 
OCP 
No 
Prior 
DVT 
or PE 
No Calf 
Symptoms
1 
No 
Surgery 
or 
Trauma 
in 4 
Weeks 
Score 
1 X  X X X X N/A X
2 
7 
2 X X  X X  N/A X 6 
3 X X X X X X X  7 
4 X   X  X N/A X 5 
5 X X X X X X X  7 
6 X  X X X X   5 
7 X  X X  X N/A X 6 
8 X   X X X N/A X 6 
9 X  X X  X N/A X 6 
10 X X  X X X X X 7 
11 X  X X X X N/A X 7 
12 X   X X  N/A X 5 
13 X   X X X N/A X 6 
14 X  X X X  X X 6 
15 X  X X X  N/A  5 
16 X X X X X X N/A X
2
 8 
17 X  X X X X N/A X 7 
18 X  X X X X  X 6 
19 X  X X  X  X 5 
20 X X  X X X  X 7 
21 X  X X  X N/A X 6 
22 X X X X  X N/A X 7 
23 X X  X  X N/A X 6 
24 X X X X  X X X 7 
25 X   X X X N/A X 6 
1. When calculating the PERC scores, if a calf exam was not record or available, it was assumed 
that the calf exam would have been normal and without symptoms, thus meeting the PERC 
criterion. 
2. The PERC rule requires no surgery or trauma within 4 weeks, but we would like to note that 
these patients had surgery or trauma within 6 months of being diagnosed with PE. 
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Table 9. PERC score comparison between patients with and without PE. 
Patients receiving a score of 8 were recorded as PERC positive or very low risk 
of PE, while patients receiving a score of less than 8 were recorded as PERC 
negative.  
Score 
PE (n = 25)  
[N (%)] 
No PE (n = 127)  
[N (%)] 
Positive ( = 8) 24 (96) 116 (91) 
Negative ( < 8) 1 (4) 11 (9) 
 
Table 10. Performance of clinical decision rules for PE. This study evaluated the 
performance of two clinical decision rules (Modified Wells Criteria and PERC 
Rule) in children presenting with symptoms of PE in an ED setting, with respect 
to sensitivity, specificity, positive and negative predictive values, and positive and 
negative likelihood ratios.  
(% [95% CI]) Modified Wells Criteria PERC Rule 
Sensitivity 64 [43,81] 96 [78,100] 
Specificity 54 [45,63] 9 [5,15] 
Positive Predictive Value 22 [13,33] 17 [12,25] 
Negative Predictive Value 89 [79,94] 92 [60,100] 
Positive Likelihood Ratio 1.40 1.05 
Negative Likelihood Ratio 0.71 0.95 
 
 
 31 
DISCUSSION 
Due to the rising rates of incidence and subsequent risk of morbidity and 
mortality of PE in children, the accurate evaluation of PE is becoming more 
necessary. Literature is fairly scarce on the evaluation and treatment of PE in a 
pediatric population, mainly due to the rarity of the condition and difficulty 
diagnosing PE. However, PE has been well studied in adults and many clinical 
decision rules have been created and validated (Wells et al. 1998; Wolf et al., 
2008; Hugli et al., 2011). Thus, most of the current diagnosing and treatment 
methods are extrapolated from adult studies (Patocka & Nemeth, 2012). Our 
study analyzed a population of children in an ED setting to better characterize 
signs and symptoms of PE and create a clinical decision rule specifically for 
children. 
 In our study, the age of our patient population ranged from 3.16 to 20.03 
years, with the median being 15.9 years and the mean being 15.0 years. 
Although the literature strongly supports a bimodal distribution of age, with peaks 
in infancy less than 12 months and in adolescence, our population showed a 
single peak and was typically older adolescents (Place, 2005). In our overall 
population presenting to the ED the  youngest patient was 3.16 years old, while 
in our PE diagnosed population (n=25) the youngest patient was 6 years old. 
Possible reasons we did not see a bimodal distribution of age amongst our 
population could be due to most neonates being treated at the adult tertiary care 
center affiliated with our hospital, or neonates having other diagnostic imaging 
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performed instead of CTPA and V/Q scanning. Both of these possibilities would 
explain the lack of children less than one year of age in our population. However, 
it is possible that our population does not support the described bimodal age 
distribution. 
The most common clinical findings for our population were chest pain, 
shortness of breath, fever, and cough, which is supported by the existing 
literature (Dijk et al., 2012; Johnson et al., 2010). Although we found no statistical 
differences for the most common clinical findings – chest pain, shortness of 
breath, fever, and cough – between patients with and without PE, our population 
with PE typically had higher frequencies of these historical and clinical findings 
relative to those patients without diagnosed PE, as seen in Table 4. Several 
studies and reviews claim that hemoptysis, or coughing up blood, is another 
highly common clinical finding, yet it was not reported for any of the patients 
diagnosed with PE and only in four (3.1%) of patients without PE in our study 
(Babyn et al., 2005; Johnson et al., 2010; Dijk et al., 2012). However, in 2009, a 
study performed by Biss et al. with 50 children with PE showed hemoptysis was 
only present in 4% of patients with no significant difference between children with 
and without PE. With no patients presenting with hemoptysis, Lee et al. also 
indicated that hemoptysis was not a significant clinical finding (Lee et al., 2012). 
In association with the two aforementioned studies, our findings suggest that 
while hemoptysis might be a significant clinical finding in adults, in children it 
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might not play a major role in the presentation of PE and would lack utility in a 
clinical decision rule for the pediatric population.  
When comparing our population of children with PE with those of Biss et 
al. and Lee et al., we found some similarities among clinical findings even though 
the populations varied in patient location (ED versus inpatient). The median and 
mean ages of all three studies were in adolescence. The median ages for 
children diagnosed with PE in our study and Biss et al. were 15.9 and 12 years, 
respectively (Biss et al., 2008). The mean age found by Lee et al. was 13.6 years 
(Lee et al., 2012). Literature indicates that pleuritic chest pain is one of the most 
frequent complains of adolescents (Bernstein et al., 1986). Our findings show 
that pleuritic chest pain was found in over half (52%) of the children diagnosed 
with PE, while Biss et al. and Lee et al. found 32.1% and 42% of patients with PE 
presented with pleuritic chest pain (Biss et al., 2008, Lee et al., 2012). Shortness 
of breath is also evident as one of the most frequent symptoms among children 
with PE (Place, 2005; Dijk et al., 2012). We found that 44% of our patients 
presented with shortness of breath, while Biss et al. and Lee et al. had relatively 
higher percentages of patients presenting with this clinical finding at 57.1% and 
47%, respectively (Biss et al., 2008, Lee et al., 2012). Although it is not 
significant independently, both of these clinical findings would be important to 
include in a clinical decision rule for children with PE because it is well 
documented in this population.  
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It should be noted that Lee et al. and our patient population did overlap by 
81 children. In their study population, 81 patients presented to the ED for 
evaluation of PE between 2004 and 2011, whereas our study population 
consisted of 152 presented to the ED between 2000 and 2012. Lee et al. had 1 
patient (3.0%) and Biss et al. had 15 (28.6%) of patients from the ED diagnosed 
with PE, while our study had 25 patients (16.4%) diagnosed with PE, making our 
study the largest retrospective cohort of patients known to be diagnosed with PE 
specifically in an ED setting (Lee et al., 2012; Biss et al., 2008). 
Although none of the most common findings were significant in our study, 
one clinical finding that was statistically significant was upper extremity swelling. 
We found that children with PE are more likely to have upper extremity swelling 
than those without PE (P value = 0.000). Upper extremity swelling is not known 
to be a common finding in adults with PE, making a possible difference between 
presentation of PE in adults and children. The literature has noted that upper 
extremity DVTs are more common in children, relative to adults, likely due to the 
use of CVCs (Johnson et al., 2010; Babyn et al., 2005; Dijk et al., 2012). 
Previous studies have shown that there are multiple predisposing factors 
for PE in children, which are summarized in Figure 1. These are typically a 
combination of comorbidities and risk factors known to be commonly present in 
patients diagnosed with PE. Our univariate analysis found that none of the 
comorbidities or risk factors we studied were statistically significant 
independently. This might indicate that presence of multiple risk factors play a 
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role in the presentation of PE in children. Several studies emphasize that children 
evaluated for PE typically have more than one comorbidity and/or risk factors 
(Lee et al., 2012; Babyn et al., 2005; Biss et al., 2008). Our study found that 
28.3% of children with PE had 2 or more risk factors of VTE, while Biss et al. and 
Lee et al. reported that 75% and 94% of children with PE presented with 2 or 
more risk factors, respectively (Lee et al., 2012; Biss et al., 2008). 
The three most common risk factors found within our population of 
patients diagnosed with PE were immobility (20%), recent surgery within 6 
months (24%), and presence of a CVC (16%). Although these were the most 
common risk factors, none of these three risk factors were show to have an 
independently significant relationship between children with or without PE. Biss 
et al. had the same three most common risk factors in their study – immobility 
(58.9%), recent surgery (28.6%), and presence of a CVC (35.7%). In 2012, Lee 
et al. found five significantly independent risk factors for PE. These risk factors 
were immobilization, indwelling CVC, previous PE and/or DVT, hypercoagulable 
state, and use of OCP. While we found that 20.0% of patients with PE had 
immobilization as a risk factor, Lee et al. found 75% of their patients presented 
with this risk factor. The large percentage difference between our finding and the 
other two studies could be that over 92% and 73.2% of the population in Lee et 
al. and Biss et al. were hospitalized patients. Overall, the literature strongly 
supports our finding of immobility to be a frequent risk factor of PE and DVT in 
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children, emphasizing that this risk factor should be included in a clinical decision 
for pediatric PE.  
Numerous studies suggest that the most important risk factor for PE in 
children is an indwelling CVL or CVC (Patocka & Nemeth, 2012; Biss et al., 
2008; Lee et al., 2012). Out of 152 patients, 22 (14.5%) presented with a CVC 
during the evaluation for PE, while 4 (16.0%) of 25 patients diagnosed with PE 
had a CVC concurrently. When comparing the association of CVC with PE 
between children with and without PE, the resulting P value was 0.812. Possible 
reasons for our study to have such poor statistical significance in contrast to the 
literature’s strong evidence of CVC as a risk factor for PE in children are: 1) Low 
number of children under one year of age and 2) Our population does not include 
hospitalized patients. Neonates and infants are known to have a high risk for 
thrombosis and typically have PE due to the present of a CVC, so the lack of this 
subpopulation would significantly affect our results, especially results concerning 
CVCs (Babyn et al., 2005; Patocka & Nemeth, 2012).  In addition, our population 
consists of children who presented to the ED and not patients who were currently 
hospitalized. Currently hospitalized children are more likely to have a concurrent 
indwelling CVC during the diagnosis of PE when compared to children who are in 
an ED setting during the diagnosis of PE possibly because of current conditions 
or illnesses requiring medical care and treatment, such as malignancies. 
Literature shows that about 30 – 60% of pediatric patients diagnosed with 
PE have simultaneous DVT (Babyn et al., 2005). Out of the 25 patients in our 
 37 
study diagnosed with PE, only 3 (12.0%) patients had a prior DVT or current DVT 
diagnosed before seen in the ED. However, looking at our entire population of 
those suspected with PE, 7.9% of the study population had history of a 
previously diagnosed DVT. Five (20%) patients were diagnosed with a DVT 
during the evaluation and concurrent diagnosis of PE. One of the patients who 
had a DVT positive ultrasound (US) result had an upper extremity DVT. There 
was a significant relationship found between patients with a diagnosis of DVT 
and a diagnosis of PE (P value = 0.000).  
Patients with a hypercoaguable state or thrombophilia are at an increased 
risk for DVT and PE because these patients have a congenital or acquired blood 
abnormality (Babyn et al., 2005). The literature shows evidence that 9 – 35% of 
patients having a thrombotic event also have either a congenital or acquired 
thrombophilic condition, with this incidence rising upwards of 52% in adolescents 
(Dijk et al., 2012). In our study, we had only one patient with hypercoagulability, 
more specifically Factor V Leiden. Lee et al. found 22% of their patients had a 
hypercoaguable state and that this risk factor was statistically significant between 
children with PE and without; however, our study did not find this risk factor 
significant between our PE and non-PE populations (Lee et al., 2012). One 
reason the presence of thrombophilia might have been low in our study as well 
as in the overall general population is that very few patients have been tested for 
these conditions (Dijk et al., 2012). 
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Another risk factor of PE and DVT that has become more prevalent 
among adolescents and young adults is the use of oral contraception (Winkler, 
1998; Gomes & Deitcher, 2004; Place, 2005). Literature shows that OCPs 
increase the risk of VTE by 2 – to 6-fold (Gomes & Deitcher, 2004). Literature 
shows that OCP use typically leads to an increase in coagulation factors and 
subsequent increased in coagulation activity (Winkler, 1998). We found that 23 
(15.1%) patients in our overall population were currently on an oral contraceptive, 
while 8 of those patients were diagnosed with a PE during their ED encounter. 
With 32% of patients diagnosed with PE, current use of OCP was found to be a 
significant risk factor for PE (P value = 0.010).  Comparing our findings with those 
of Biss et al. (roughly 7%) and Lee et al. (22%), we found that we had a higher 
percentage of patients presenting with use of OCPs (or excess estrogen state) 
as a risk factor (Biss et al., 2008; Lee et al., 2012). One reason our study had a 
relatively higher percentage of patients on OCPs could be due to the fact that we 
had a higher percentage of females (63.8%) and adolescents in our population. 
Patients taking OCPs are also known to be at higher risk so may be imaged 
more frequently. Due to the shown significance of this risk factor in numerous 
studies, including our own findings, we feel that use of OCPs should be a 
potential criterion for a clinical decision rule for the evaluation of PE in a pediatric 
population.  
 Physical findings that we found to be significant between patients 
diagnosed with PE and those without PE were an abnormal lung exam and triage 
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O2 saturation levels. We defined an abnormal lung exam as a lung exam 
recorded in the ED note with any of the following findings: crackles or rales, 
coarse breathing sounds, wheezes, decreased breathing sounds, and 
tachypnea. Ten (40%) children with PE presented with an abnormal lung exam, 
with the most common finding among these children was tachypnea (n=5). 
Although several studies mention tachypnea as a common physical finding, this 
physical finding or any of the previously mentioned abnormal lung findings have 
not been found to have a statistically significant association with a diagnosis of 
PE in children (Dijk et al., 2012; Patocka & Nemeth, 2012).  
Another frequently mentioned physical finding among children with PE is 
hypoxemia (Place, 2005; Dijk et al., 2012). Using the triage vital signs from the 
patients’ EMR, we performed a statistical comparison of O2 saturation values 
between children with and without PE and found there to be a statistically 
significant difference with a P value of 0.003. The median O2 saturation level in 
children with PE was 97% (IQR [94, 99]), while among children without PE the 
median value was 99% (IQR [98, 100]).  Even though a low O2 saturation level is 
not a specific finding for PE, this physical finding could be an important criterion 
in a clinical decision rule for pediatric PE, especially in the ED.      
Along with those physical finding results, we believe that tachycardia 
might play an important role as well in children presenting with PE. We did not 
find triage heart rates to have a significant difference between children with or 
without PE (P value = 0.162). The reason physical findings, especially vital signs, 
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might appear normal could be due to the fact that a larger cardiopulmonary 
reserve is typically found in children, relative to adults (Place, 2005). However, 
reviewing the maximum heart rate values recorded in the EMR over the entire 
ED visit, we found 76% of our patients diagnosed with PE presented at some 
point during their encounter with tachycardia (HR > 100 bpm), with the median 
being 104 bpm. Due to this finding as well as the knowledge that children usually 
have a larger cardiopulmonary reserve, we believe that presence of tachycardia 
could also be a useful criterion in a clinical decision rule for a pediatric 
population. 
The literature shows that the D-dimer assay in the evaluation of clinically 
suspected PE in an adult population is a good predictive tool; however, in 
pediatric populations, the literature highlights that this predictive tool lacks utility 
(Biss et al., 2008; Biss et al., 2009). Table 4 shows that although the patients 
diagnosed with PE typically have slightly higher D-dimer values, both populations 
typically have D-dimer values above the 2.50 mg/L FEU cutoff point. Reasons 
explaining why both populations have D-dimer values typically considered 
positive results could be due to D-dimer assays being sensitive, yet not specific 
for PE. D-dimer values can be elevated due to numerous conditions besides PE, 
such as trauma, recent surgery, and malignancy (Johnson et al., 2010). We 
found that although a D-dimer value was found positive in about 72% of patients 
with PE, D-dimer values were also positive in almost 68% of patients without PE.  
In addition, roughly 28% of patients with PE had negative D-dimer values (Table 
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5). In 2009, Biss et al. also discovered a similar pattern in their study of D-dimer 
results in a pediatric population, with negative D-dimer values in 15% of patients 
diagnosed with PE. Like Biss et al. and Lee et al., we found that there is no 
statistically significant relationship between D-dimer values and diagnosis of PE 
in children (Biss et al., 2009; Lee et al., 2012).  
 To guide our statistical analysis and development of a clinical decision 
rule, we used common evaluation models against our patient population. The first 
clinical score model we used was the Wells simplified probability score for PE. 
Table 6 shows the scores for the 25 patients diagnosed with PE in our study. We 
found that the sensitivity of this score was 64% (95% CI, 43 – 81%), while the 
specificity was 54% (95% CI, 45 – 63%). When we compare our findings and 
Wells simplified scores with those findings in the Biss et al. study in 2009, we see 
that these criteria are not as frequent or significant in children with PE, relative to 
adults, and therefore might lack the ability to successfully differentiate children 
with and without PE. The literature strongly supports the use of the Wells 
probability score for the evaluation of PE in adults, yet our findings suggest, in 
association with Biss et al., that this evaluation method lacks utility in the 
pediatric population (Wolf et al., 2004; Biss et al., 2009). Thus, there is a 
necessity to find criteria specific to children that will be able to differentiate 
between children with and without PE. There are a couple of limitations to the 
Wells simplified probability scores for our patients. Firstly, the Wells criteria of 
“diagnosis of PE most likely” should be prospectively documented, yet due to the 
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nature of our study, this criteria was met using retrospective data from the 
differential diagnosis. We therefore erred on the side of caution by assuming the 
diagnosis of PE was most likely if considered in the differential diagnosis. 
Secondly, none of our patients diagnosed with PE had hemoptysis as a clinical 
symptom. Even in spite of our limitations, our results show that the Wells 
simplified probability score is not sensitive in evaluating PE in children. 
The second model we used was the PE Rule-out Criteria (PERC) rule, 
which is applied to patients to rule-out those who can be considered to have a 
very low risk for PE (Hugli et al., 2011; Wolf et al., 2008). According to the PERC 
rule, a patient must meet all 8 criteria listed in Table 2 in order to be ruled as 
having a very low risk of PE. Therefore, if patients do not receive a score of 8 
points, then they cannot safely be ruled out. To the best of our knowledge no 
other study has applied the PERC rule to a pediatric population, and more 
specifically a pediatric population in an ED setting. When we applied this to our 
patient population, we found that one of our patients diagnosed with PE were 
considered very low risk for PE according to the PERC rule (Table 7); thus, the 
sensitivity was 96% (95% CI, 78 – 100%). Although the sensitivity was high in 
our study, the specificity was 9% (95% CI, 5 – 15%) emphasizing that this clinical 
decision rule does not contribute significantly in stratifying patients with and 
without PE presenting with symptoms. One of the limitations of using the PERC 
score in a pediatric population is that every patient would start off with a score of 
1.0 because everyone would be below 50 years of age. In our study, the PERC 
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scores might have been higher than in adult populations because everyone 
started off with 2.0 points – one point for being below 50 years old and one point 
for no hemoptysis. Another limitation of our PERC scores is that the PERC rule is 
designed to detect patients at low risk for PE and our population can be viewed 
as at a high risk for PE, due to the nature of how we selected our population – 
patients who underwent a CTPA or V/Q scan. Our population was known to be 
high risk, so with a sensitivity of 96% we found that the PERC rule when applied 
for this population works well.  
We plan to take these results and develop a clinical decision rule specific 
for children. Looking at the Wells criteria and the PERC rule, especially when 
applied to our population, we noted that clinical findings, such as pleuritic chest 
pain and shortness of breath, are not included in either set of criteria. We aim to 
use pertinent clinical findings typically seen in children presenting with PE in 
combination with known risk factors and comorbidities as well as physical exam 
findings to establish our clinical decision rule for PE in children. The criteria we 
feel that could be used are: 1) abnormal calf exam or current DVT symptoms, 2) 
previous PE or DVT, 3) use of OCPs, 4) immobility or recent surgery, 5) an 
oxygen saturation < 95%, 6) presence of a CVC, 7) a heart rate > 100 bpm, 8) 
pleuritic chest pain, and 9) shortness of breath. Using a combination of criteria 
from literature and our findings, we will use multivariate analysis and perform 
recursive partitioning analysis to develop our clinical decision rule for children 
presenting to the ED for evaluation of PE.  
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There are several limitations to our study. First, this study was performed 
at a single, large referral children’s hospital and might not reflect the true nature 
of this condition in a pediatric population in smaller hospitals or other community 
settings. Secondly, even though our study has the largest number of pediatric 
patients diagnosed with PE presenting in an ED setting, it is still a relatively small 
population. Therefore, it is necessary that future research includes a multicenter 
prospective study of a pediatric population presenting to an ED setting. Thirdly, 
we know that our definition of immobility is subjective and that the analysis of 
immobilization as a risk factor for PE might reflect bias. However, to minimize 
potential error in order to more accurately analyze this risk factor in our study, we 
used a strict adherence to specific inclusion criteria in regards to immobilization. 
Finally, there are some limitations to our study of our D-dimer data. We used 
2.50 mg/L FEU as our cutoff point, even though this value has not been validated 
as significant in D-dimer assays in children. Also, not everyone in our population 
had a D-dimer value obtained, including some of the children diagnosed with PE 
because it is not currently required for physicians to order this test in all children 
clinical suspected of having PE.  
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CONCLUSION 
The results of this study describe a high risk population of children 
evaluated for PE presenting to an ED setting. We identified several historical, 
clinical, and physical exam findings that are independently associated with 
diagnosis of PE. The current use of OCPs, abnormal lung exam, and oxygen 
saturation level were all findings that were more likely to be present in patients 
with PE. The next step will be to use our descriptive analysis to develop a clinical 
decision rule for the evaluation and diagnosis of PE in children in an ED setting. 
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